/Investor DB

INCE Capital — 2024 Investments

2 investments dated 2024 · listed companies and verified rows first · show all

UXLINKuxlink.ioin𝕏May 2024✓ verified

UXLINK is a Web3 social platform and infrastructure that connects users and projects through account abstraction and cross-chain functionality.

Crypto & Web3Developer ToolsSocialTokyo, JP

Co-investorsHashkey CapitalHongShan Capital GroupKuCoin LabsManifoldManifold VenturesOKX Ventures+2 more

Avenzoavenzotx.cominNov 2024

Avenzo Therapeutics is a clinical-stage biopharmaceutical company developing therapeutic treatments.

BiotechSan Diego, US

Athena Countouriotis(Co-Founder, Chief Executive Officer)Mohammad Hirmand(Executive Officer)inPaolo Tombesi(Executive Officer)inScott Lipman(Executive Officer)inBrian Sun(Executive Officer)in

BoardCarl Gordon(Director)

Co-investorsDelos CapitalForesite CapitalLongwood FundNew Enterprise Associates (NEA)OrbiMedQuan Capital+6 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.